Search

everythinglearnresearchcommunity

for

Search:↓

Urotensin II increases growth and VEGF production in rat skin cells by turning on the Wnt-β-catenin pathway.

Baricitinib is a promising treatment for alopecia areata.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

Janus kinase inhibitors may help treat lichen planopilaris.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

A rare skin infection in a 10-year-old kidney transplant patient was successfully managed by adjusting medication.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Cancer treatments often cause skin, nail, and hair problems.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Upadacitinib may effectively treat resistant lichen planopilaris.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.